MedTrace Logo

The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness

NCT02909426 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 11880

Last updated 2021-10-07

No results posted yet for this study

Summary

Mammography screening has limited performance in young women or women with dense breasts although it is the only proven method for breast cancer screening that reduces the mortality. The investigators propose a multicenter trial of breast cancer screening to assess the effectiveness of supplemental ultrasonography for Korean women aged 40-59 years.

Conditions

  • Invasive Cancer
  • Ductal Carcinoma in Situ

Interventions

DEVICE

Ultrasonography

Radiologists' hand-held bilateral breast ultrasonography for each participant for one time

DEVICE

Digital mammography

Full-field digital mammography using one of the equipments from General Electric (GE), Hologic, and Medi-future companies for each participant for one time

Sponsors & Collaborators

  • Ministry of Health & Welfare, Korea

    collaborator OTHER_GOV

  • Soonchunhyang University Hospital

    lead OTHER

Principal Investigators

  • EUN HYE LEE, MD, Ph.D · Soonchunhyang University Hospital

Eligibility

Min Age
40 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-02
Primary Completion
2020-12-31
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02909426 on ClinicalTrials.gov